/CNW/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein purification, today announced that it was recognized as one of Canada's Top 10 Life Science Companies. Canada's Top 10 Life Science Companies are evaluated by an independent international panel of life science venture capitalists. The panel selects companies based on their attractiveness as an exceptional investment in Canada, and Norgen Biotek was chosen as one of these companies. "We are delighted to have been chosen for this celebrated award, it recognizes our impressive achievements," said Dr. Yousef Haj-Ahmad, President & CEO of Norgen Biotek Corp. "This prestigious award recognizes Norgen Biotek's achieved milestones and future prospectus."
About Canada's Top 10:
The prestigious Canada's Top 10 competition was invented in 1999 to promote the ten most promising life science companies chosen from a pool of entrants by an independent international jury of life science venture capitalists. Based on their expert knowledge of investment in the life science sector, the jury selects companies that offer the best investment and partnership prospects. Further information is available at: www.topcanadiancompanies.ca.